MR. ROBERT LAMAR EYSTER, M.D.

WICHITA, KS

Research Active
Orthopaedic Surgery NPI registered 21+ years 1 publication 1985 – 1985 NPI: 1063416048
Orthopaedic Surgery
MiceNorepinephrineRatsElectric StimulationStructure-Activity RelationshipDepressionDrug SynergismChemical PhenomenaChemistryAggressionDrug EvaluationCerebral CortexAmidinesBlepharoptosisReserpine

Practice Location

1131 S CLIFTON AVE
WICHITA, KS 67218-2955

Phone: (316) 858-1600

What does ROBERT EYSTER research?

Dr. Eyster studies the efficacy of new types of antidepressants, particularly a compound called napactadine and its derivatives. His research seeks to improve current treatments for depression by exploring alternative options that could be just as effective as existing medications. This is important for individuals who find that their current treatments are not working well or have undesirable side effects.

Key findings

  • Some new compounds developed by Dr. Eyster were found to be as active as the existing antidepressant imipramine, which is significant for treatment advancements in depression.
  • The research provides potential for new antidepressants that may better serve patients who do not respond adequately to current therapies.
  • The study highlights the importance of exploring alternative medications in treating depression, which can benefit a wide range of patients.

Frequently asked questions

Does Dr. Eyster study depression?
Yes, Dr. Eyster specifically researches new antidepressants to help individuals dealing with depression.
What antidepressants has Dr. Eyster researched?
Dr. Eyster has researched napactadine and related compounds as new potential antidepressants.
Is Dr. Eyster's work relevant to patients who are not helped by current treatments?
Yes, his work aims to provide better options for those who struggle with existing antidepressants.

Publications in plain English

New bicyclic antidepressant agent. Synthesis and activity of napactadine and related compounds.

1985

Journal of medicinal chemistry

McCarthy JR, Wright DL, Schuster AJ, Abdallah AH, Shea PJ +1 more

Plain English
Researchers developed a new type of antidepressant called napactadine and other related compounds to see if they could be as effective as existing treatments. They found that some of these new compounds were as active as the commonly used antidepressant imipramine. This matters because it could lead to better options for people struggling with depression. Who this helps: This helps patients dealing with depression.

PubMed

Frequent Co-Authors

J R McCarthy D L Wright A J Schuster A H Abdallah P J Shea

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.